Work

A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy

Year: 2010

Type: article

Study design: Clinical Trial

Source: Anti-Cancer Drugs

DOI: 10.1097/cad.0b013e3283355211

Authors: Tomasz M. Beer, Charles Ryan, Joshi Alumkal, Christopher W. Ryan, Janine Sun, Kristine M. Eilers

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Department of Defense

OpenAlex ID: W2039501159

FWCI: 5.157

Cites: 19

Cited by: 43

Related to: 10